Contraception for Women With Psychiatric Disorders
- PMID: 33167674
- DOI: 10.1176/appi.ajp.2020.20020154
Contraception for Women With Psychiatric Disorders
Abstract
Objective: Mental health care for women includes decision support to prepare for major life events, including preconception planning for treatment during pregnancy and the postpartum period. The authors discuss contraceptive choices and their effectiveness, side effects, and impact on psychiatric symptoms. The Centers for Disease Control and Prevention's recommendations, Medical Eligibility Criteria for Contraceptive Use, provided the structure for review of contraceptive choices.
Methods: A search of PsycINFO, PubMed, Embase, and Scopus was conducted for publications on the management of contraception for women with mental illness. Publications were selected if they included, based on the authors' consensus, data supporting evidence-based care important for psychiatrists who treat women desiring contraceptives.
Results: The majority of women choose combined oral contraceptives. Although long-acting reversible contraceptives (implants, intrauterine devices) are associated with low failure rates, favorable safety profiles, rapid return to fertility after removal, and few contraindications, they are chosen by only 14% of women. All methods are acceptable for women with depression, although medical comorbidities may dictate a specific type. The impact of hormonal contraceptives on the risk for depression is controversial; however, clinical studies and randomized placebo-controlled trials of women with psychiatric disorders have generally reported similar or lower rates of mood symptoms in hormonal contraceptive users compared with nonusers. Although interactions between psychotropic drugs and contraceptives are rare, clozapine, anticonvulsants, and St. John's Wort are exceptions.
Conclusions: Proactive management of mental illness, contraception, and pregnancy improves a woman's capacity to function and optimizes her mental and reproductive health.
Keywords: Contraception; Depot Medroxyprogesterone Acetate; Depression; Intrauterine Device; Oral Contraceptive; Women’s Health.
Comment in
-
Treatment of Psychiatric Conditions in Pregnancy Starts With Planning.Am J Psychiatry. 2021 Mar 1;178(3):213-214. doi: 10.1176/appi.ajp.2020.20121791. Am J Psychiatry. 2021. PMID: 33641379 No abstract available.
Similar articles
-
Canadian Contraception Consensus (Part 1 of 4).J Obstet Gynaecol Can. 2015 Oct;37(10):936-42. doi: 10.1016/s1701-2163(16)30033-0. J Obstet Gynaecol Can. 2015. PMID: 26606712 English, French.
-
Canadian Contraception Consensus (Part 2 of 4).J Obstet Gynaecol Can. 2015 Nov;37(11):1033-9. doi: 10.1016/s1701-2163(16)30054-8. J Obstet Gynaecol Can. 2015. PMID: 26629725 English, French.
-
Combined hormonal contraception use in reproductive-age women with contraindications to estrogen use.Am J Obstet Gynecol. 2016 Sep;215(3):330.e1-7. doi: 10.1016/j.ajog.2016.03.047. Epub 2016 Apr 5. Am J Obstet Gynecol. 2016. PMID: 27059507 Free PMC article.
-
Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.Am J Obstet Gynecol. 2017 Feb;216(2):101-109. doi: 10.1016/j.ajog.2016.08.033. Epub 2016 Sep 20. Am J Obstet Gynecol. 2017. PMID: 27662799 Free PMC article. Clinical Trial.
-
Contraceptive choices for behaviorally disordered women.Am J Obstet Gynecol. 1993 Jun;168(6 Pt 2):1986-9. doi: 10.1016/s0002-9378(12)90939-4. Am J Obstet Gynecol. 1993. PMID: 8512042 Review.
Cited by
-
Premenstrual Exacerbations of Mood Disorders: Findings and Knowledge Gaps.Curr Psychiatry Rep. 2021 Oct 9;23(11):78. doi: 10.1007/s11920-021-01286-0. Curr Psychiatry Rep. 2021. PMID: 34626258 Free PMC article. Review.
-
Contraception in adolescents with mental disorders: adherence and satisfaction in the use of depot medroxyprogesterone acetate.Rev Bras Ginecol Obstet. 2025 Mar 17;47:e-rbgo9. doi: 10.61622/rbgo/2025rbgo9. eCollection 2025. Rev Bras Ginecol Obstet. 2025. PMID: 40242009 Free PMC article.
-
Medroxyprogesterone acetate and meningioma: a global issue.Front Glob Womens Health. 2025 Mar 26;6:1470539. doi: 10.3389/fgwh.2025.1470539. eCollection 2025. Front Glob Womens Health. 2025. PMID: 40207201 Free PMC article. No abstract available.
-
Prevalence and correlates of depressive symptoms, and points of intervention, in rural central Uganda: results from a cross-sectional population-based survey of women and men.BMJ Open. 2022 May 31;12(5):e054936. doi: 10.1136/bmjopen-2021-054936. BMJ Open. 2022. PMID: 35641013 Free PMC article.
-
Contraceptive use and counselling in women with mental illness: KwaZulu-Natal, South Africa.S Afr J Psychiatr. 2025 Jun 4;31:2397. doi: 10.4102/sajpsychiatry.v31i0.2397. eCollection 2025. S Afr J Psychiatr. 2025. PMID: 40612429 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical